Hepatocellular carcinoma and hepatitis B surface protein

World Journal of Gastroenterology : WJG
Yong-Wei LiJiong-Shan Zhang

Abstract

The tumorigenesis of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) has been widely studied. HBV envelope proteins are important for the structure and life cycle of HBV, and these proteins are useful for judging the natural disease course and guiding treatment. Truncated and mutated preS/S are produced by integrated viral sequences that are defective for replication. The preS/S mutants are considered "precursor lesions" of HCC. Different preS/S mutants induce various mechanisms of tumorigenesis, such as transactivation of transcription factors and an immune inflammatory response, thereby contributing to HCC. The preS2 mutants and type II "Ground Glass" hepatocytes represent novel biomarkers of HBV-associated HCC. The preS mutants may induce the unfolded protein response and endoplasmic reticulum stress-dependent and stress-independent pathways. Treatments to inhibit hepatitis B surface antigen (HBsAg) and damage secondary to HBsAg or the preS/S mutants include antivirals and antioxidants, such as silymarin, resveratrol, and glycyrrhizin acid. Methods for the prevention and treatment of HCC should be comprehensive.

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·W H CaselmannR Koshy
Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K YaginumaK Koike
Jan 1, 1987·Annual Review of Biochemistry·D Ganem, H E Varmus
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F V ChisariR L Brinster
Mar 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·M A GerberH Popper
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M GarciaA Dejean
Jan 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P PaterliniC Bréchot
May 1, 1996·Antiviral Research·H SatoK Shiraki
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·A de La CosteC Perret
Feb 23, 1999·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·E Hildt, P H Hofschneider
Jun 29, 1999·Advances in Virus Research·S GüntherH Will
Dec 22, 1999·Journal of Viral Hepatitis·S ZhongP J Johnson
Jan 5, 2000·The Journal of Clinical Investigation·P SoussanD Kremsdorf
Apr 1, 2000·Transplant International : Official Journal of the European Society for Organ Transplantation·K NarumotoN Kobayashi
Apr 4, 2000·Journal of Medical Virology·S AlkaP S Kumar
Dec 22, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y F FanI J Su
Aug 2, 2001·Journal of the National Cancer Institute·I Horikawa, J C Barrett
Jan 1, 1996·Journal of Biomedical Science·T.S.B. Yen
Feb 16, 2002·The EMBO Journal·Eberhard HildtPeter Hans Hofschneider
Jul 19, 2002·The New England Journal of Medicine·Hwai-I YangUNKNOWN Taiwan Community-Based Cancer Screening Project Group
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Manal M HassanYehuda Z Patt
Dec 12, 2003·Journal of Virological Methods·Matsuo DeguchiIsa K Mushahwar
Dec 31, 2003·Gastroenterology·Teresa PollicinoGiovanni Raimondo
Mar 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Shuang-Yuan KuangJohn D Groopman
Mar 31, 2004·Cancer Cell·Jordi BruixJosep M Llovet
Nov 16, 2004·Journal of Virology·Michael J Bouchard, Robert J Schneider
Feb 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hui-Ching WangIh-Jen Su
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Chien-Jen ChenUNKNOWN REVEAL-HBV Study Group
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Snorri S ThorgeirssonJoe W Grisham
Mar 25, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Matthias EngelkeStephan Urban
Jul 25, 2006·Cancer Biology & Therapy·Andrew Fribley, Cun-Yu Wang
Sep 21, 2006·Cancer Science·Hong TangSeishi Murakami

❮ Previous
Next ❯

Citations

Aug 10, 2016·Current Opinion in Virology·Elham Shirvani-DastgerdiAlexander Ploss
Jan 18, 2017·Hepatology International·Ming WangQin Ning
Dec 1, 2017·Journal of Clinical Medicine·Uyen Ngoc MuiStephen K Tyring
Aug 15, 2018·Biological Reviews of the Cambridge Philosophical Society·Wai Yeow LeeCaroline G Lee
Jan 13, 2018·International Journal of Molecular Medicine·Guannan WangQiang Huang
Sep 9, 2020·Journal of Viral Hepatitis·Citrawati Dyah Kencono WunguRetno Handajani
Jan 19, 2018·Reviews in Medical Virology·Habibollah Mirzaei, Ebrahim Faghihloo
Aug 23, 2018·World Journal of Gastroenterology : WJG·Chun-Chen WuMeng-Ji Lu
Jun 20, 2020·Journal of Gastroenterology·Lilian Yan LiangGrace Lai-Hung Wong
Dec 29, 2020·The International Journal of Biochemistry & Cell Biology·Yaming LiuJianlin Ren
Mar 22, 2019·DNA Repair·Amanda K McCullough, R Stephen Lloyd
Nov 2, 2021·Journal of Viral Hepatitis·Huai-Lung ChangHuey-Ling Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.